IN THE NEWS Featured September 10, 2025 Awards & Announcements, In the News Lactiga Wins NIH Backing for First-in-Class Breastmilk-Derived Antibody in Inflammatory Bowel Disease September 10, 2025 Awards & Announcements, In the News September 10, 2025 Awards & Announcements, In the News September 10, 2025 In the News Kenox and Lactiga partner on sIgA therapies for immunodeficiency September 10, 2025 In the News September 10, 2025 In the News September 10, 2025 In the News As good as gold September 10, 2025 In the News September 10, 2025 In the News February 3, 2025 In the News, Awards & Announcements Lactiga Secures Multi-Year, Multi-Million Dollar Grant February 3, 2025 In the News, Awards & Announcements February 3, 2025 In the News, Awards & Announcements January 5, 2025 In the News ValiantCEO | Viraj Mane, Lactiga – Developing Novel Antibodies for Mucosal Infections in Rare Immunodeficiencies January 5, 2025 In the News January 5, 2025 In the News September 25, 2023 Publications, In the News In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19 September 25, 2023 Publications, In the News September 25, 2023 Publications, In the News August 14, 2023 In the News, Awards & Announcements Lactiga Gets FDA Rare Pediatric Disease Designation for CVID Therapy August 14, 2023 In the News, Awards & Announcements August 14, 2023 In the News, Awards & Announcements October 6, 2022 In the News Lactiga in the Toronto Star October 6, 2022 In the News October 6, 2022 In the News September 21, 2022 In the News, Awards & Announcements Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants September 21, 2022 In the News, Awards & Announcements September 21, 2022 In the News, Awards & Announcements September 21, 2022 In the News, Awards & Announcements Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre-Seed Round, Secures $350k in Research Grants September 21, 2022 In the News, Awards & Announcements September 21, 2022 In the News, Awards & Announcements September 7, 2022 In the News Post-mRNA vaccine antibodies in breast milk raises protective potential for babies, and possibly adults September 7, 2022 In the News September 7, 2022 In the News October 5, 2021 In the News Not just for babies: Biotech startup taps breast milk for COVID treatment that keeps up as virus mutates October 5, 2021 In the News October 5, 2021 In the News June 13, 2021 In the News How Biotech Startup Lactiga Uses DocSend to Show Traction June 13, 2021 In the News June 13, 2021 In the News June 12, 2021 In the News Lactiga Featured in the Globe and Mail June 12, 2021 In the News June 12, 2021 In the News June 9, 2021 In the News Got milk COVID-19 antibodies? June 9, 2021 In the News June 9, 2021 In the News November 2, 2020 In the News, Awards & Announcements Checkmate Capital Group Completes Seed Investment in Lactiga, Inc. November 2, 2020 In the News, Awards & Announcements November 2, 2020 In the News, Awards & Announcements October 14, 2020 In the News, Awards & Announcements Lactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment October 14, 2020 In the News, Awards & Announcements October 14, 2020 In the News, Awards & Announcements September 1, 2020 In the News, Awards & Announcements LACTIGA USES DOCSEND DATE ROOMS FOR PROACTIVE AND PERSONALIZED FUNDRAISING September 1, 2020 In the News, Awards & Announcements September 1, 2020 In the News, Awards & Announcements
